MY187233A - Drospirenone-based contraceptive for a female patient affected with excess weight - Google Patents
Drospirenone-based contraceptive for a female patient affected with excess weightInfo
- Publication number
- MY187233A MY187233A MYPI2017704873A MYPI2017704873A MY187233A MY 187233 A MY187233 A MY 187233A MY PI2017704873 A MYPI2017704873 A MY PI2017704873A MY PI2017704873 A MYPI2017704873 A MY PI2017704873A MY 187233 A MY187233 A MY 187233A
- Authority
- MY
- Malaysia
- Prior art keywords
- drospirenone
- female patient
- patient affected
- excess weight
- contraceptive
- Prior art date
Links
- 239000003433 contraceptive agent Substances 0.000 title abstract 3
- 230000002254 contraceptive effect Effects 0.000 title abstract 3
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title abstract 2
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title abstract 2
- 229960004845 drospirenone Drugs 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510348953.1A CN106265694A (zh) | 2015-06-23 | 2015-06-23 | 用于过重女性患者的基于屈螺酮的避孕药 |
| EP15305965.4A EP3108889A1 (en) | 2015-06-23 | 2015-06-23 | Drospirenone-based contraceptive for a female patient affected with excess weight |
| PCT/EP2016/064574 WO2016207298A1 (en) | 2015-06-23 | 2016-06-23 | Drospirenone-based contraceptive for a female patient affected with excess weight |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY187233A true MY187233A (en) | 2021-09-13 |
Family
ID=56178376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2017704873A MY187233A (en) | 2015-06-23 | 2016-06-23 | Drospirenone-based contraceptive for a female patient affected with excess weight |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP3313408B1 (enExample) |
| JP (1) | JP6827962B2 (enExample) |
| KR (1) | KR102217942B1 (enExample) |
| CN (2) | CN108025014B (enExample) |
| AU (1) | AU2016282863B2 (enExample) |
| BR (1) | BR112017028048A2 (enExample) |
| CA (1) | CA2989975C (enExample) |
| DK (1) | DK3313408T3 (enExample) |
| EA (1) | EA036497B1 (enExample) |
| ES (1) | ES2970532T3 (enExample) |
| FI (1) | FI3313408T3 (enExample) |
| HR (1) | HRP20240121T8 (enExample) |
| HU (1) | HUE065350T2 (enExample) |
| LT (1) | LT3313408T (enExample) |
| MX (1) | MX389310B (enExample) |
| MY (1) | MY187233A (enExample) |
| NI (1) | NI201700173A (enExample) |
| PH (1) | PH12017502379A1 (enExample) |
| PL (1) | PL3313408T3 (enExample) |
| RS (1) | RS65196B1 (enExample) |
| SI (1) | SI3313408T1 (enExample) |
| SM (1) | SMT202400062T1 (enExample) |
| SV (1) | SV2017005602A (enExample) |
| UA (1) | UA122873C2 (enExample) |
| WO (1) | WO2016207298A1 (enExample) |
| ZA (1) | ZA201800067B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| MY195019A (en) | 2015-06-18 | 2023-01-03 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| MD3310346T2 (ro) | 2015-06-18 | 2021-06-30 | Estetra Sprl | Comprimată orodispersabilă ce conține estetrol |
| JP6866560B2 (ja) | 2015-06-18 | 2021-04-28 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| HUE054589T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Szájban diszpergálódó esztetrol tartalmú tabletta |
| MX389310B (es) | 2015-06-23 | 2025-03-20 | Laboratorios Leon Farma Sa | Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso. |
| KR102712911B1 (ko) | 2016-08-05 | 2024-10-04 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| EP4134082A1 (en) | 2021-08-12 | 2023-02-15 | Chemo Research, S.L. | Method for treating endometriosis and providing effective contraception |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652761C2 (de) | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
| DE19633685C1 (de) | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
| WO2004041288A1 (en) * | 2002-11-05 | 2004-05-21 | Schering Aktiengesellschaft | Hormone replacement therapy with drospirenone |
| CN107875388A (zh) * | 2004-04-30 | 2018-04-06 | 拜耳知识产权有限责任公司 | 对延长的激素避孕方案中突破性出血的控制 |
| MY151322A (en) * | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| EP1773344A1 (en) * | 2004-07-07 | 2007-04-18 | Wyeth a Corporation of the State of Delaware | Cyclic progestin regimens and kits |
| ITMI20042338A1 (it) | 2004-12-06 | 2005-03-06 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| ATE403668T1 (de) | 2005-07-21 | 2008-08-15 | Bayer Schering Pharma Ag | Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen |
| MX2009010763A (es) * | 2007-04-05 | 2009-10-28 | Bayer Schering Pharma Ag | NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION. |
| EP2548881B1 (en) * | 2010-03-16 | 2014-12-17 | Taizhou Taifa Pharmaceuticals Co., Ltd | Preparation method of drospirenone |
| RU2422824C1 (ru) * | 2010-05-07 | 2011-06-27 | Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи | Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела |
| US9375437B2 (en) * | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
| AR081670A1 (es) * | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| CN103372015A (zh) * | 2012-04-19 | 2013-10-30 | 国家人口计生委科学技术研究所 | 包含屈螺酮或屈螺酮和雌激素的阴道环制剂 |
| RU2527357C1 (ru) * | 2013-08-02 | 2014-08-27 | Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) | Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет |
| MX389310B (es) | 2015-06-23 | 2025-03-20 | Laboratorios Leon Farma Sa | Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso. |
-
2016
- 2016-06-23 MX MX2017016801A patent/MX389310B/es unknown
- 2016-06-23 RS RS20240118A patent/RS65196B1/sr unknown
- 2016-06-23 MY MYPI2017704873A patent/MY187233A/en unknown
- 2016-06-23 HR HRP20240121TT patent/HRP20240121T8/hr unknown
- 2016-06-23 DK DK16731177.8T patent/DK3313408T3/da active
- 2016-06-23 AU AU2016282863A patent/AU2016282863B2/en active Active
- 2016-06-23 CN CN201680045547.0A patent/CN108025014B/zh active Active
- 2016-06-23 CN CN202111154721.4A patent/CN113750108B/zh active Active
- 2016-06-23 CA CA2989975A patent/CA2989975C/en active Active
- 2016-06-23 PL PL16731177.8T patent/PL3313408T3/pl unknown
- 2016-06-23 UA UAA201712722A patent/UA122873C2/uk unknown
- 2016-06-23 LT LTEPPCT/EP2016/064574T patent/LT3313408T/lt unknown
- 2016-06-23 EP EP16731177.8A patent/EP3313408B1/en active Active
- 2016-06-23 WO PCT/EP2016/064574 patent/WO2016207298A1/en not_active Ceased
- 2016-06-23 EA EA201792595A patent/EA036497B1/ru unknown
- 2016-06-23 ES ES16731177T patent/ES2970532T3/es active Active
- 2016-06-23 JP JP2017567465A patent/JP6827962B2/ja active Active
- 2016-06-23 SI SI201631799T patent/SI3313408T1/sl unknown
- 2016-06-23 KR KR1020187001303A patent/KR102217942B1/ko active Active
- 2016-06-23 SM SM20240062T patent/SMT202400062T1/it unknown
- 2016-06-23 FI FIEP16731177.8T patent/FI3313408T3/fi active
- 2016-06-23 HU HUE16731177A patent/HUE065350T2/hu unknown
- 2016-06-23 BR BR112017028048A patent/BR112017028048A2/pt not_active Application Discontinuation
-
2017
- 2017-12-20 PH PH12017502379A patent/PH12017502379A1/en unknown
- 2017-12-21 SV SV2017005602A patent/SV2017005602A/es unknown
- 2017-12-21 NI NI201700173A patent/NI201700173A/es unknown
-
2018
- 2018-01-04 ZA ZA2018/00067A patent/ZA201800067B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502379A1 (en) | Drospirenone-based contraceptive for a female patient affected with excess weight | |
| PH12017502431A1 (en) | Pharmaceutical formulations comprising tenofovir and emtrictabine | |
| NZ742220A (en) | Pharmaceutical compositions comprising meloxicam | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| MX2016010213A (es) | Formulaciones farmaceuticas novedosas. | |
| MX390570B (es) | Composicion farmaceutica para la prevencion y/o tratamiento de dermatitis atopica que comprende antagonista de interleucina 31 (il-31) como ingrediente activo. | |
| MX2017016802A (es) | Formulaciones farmaceuticas. | |
| ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
| ZA202503387B (en) | Semaglutide in medical therapy | |
| MX2021006941A (es) | Anelosomas para suministrar modalidades terapéuticas intracelulares. | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MY200278A (en) | Methods of improving exercise capacity in fontan patients using udenafil compositions | |
| MX2018010065A (es) | Forma de dosificacion oral que comprende rifaximina en forma beta. | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| ZA201906153B (en) | Pharmaceutical compositions for combination therapy | |
| WO2017064652A3 (en) | Low dose oral dipyridamole compositions and uses thereof | |
| MX2016011706A (es) | Formulaciones de progesterona. | |
| MA39009A (fr) | Compositions pharmaceutiques comprenant un agent actif | |
| PH12019501607A1 (en) | Tapentadol nasal composition | |
| UA91282U (uk) | Фармацевтичний продукт, що має виражену антигестагенну дію | |
| UA93055U (uk) | Фармацевтична композиція для дентальної імплантації | |
| UA100790U (uk) | Спосіб лікування симптомної лейоміоми матки | |
| MD4458B1 (ro) | Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică | |
| UA91081U (uk) | Спосіб моделювання катаракти | |
| UA75807U (uk) | Спосіб профілактики порушень метаболізму кісткової тканини, пов'язаних з неприродним раціоном і дією туберкулостатиків |